| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.042 | 0.5 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |